Aleve PM is the first and only over-the-counter (OTC) PM product with the 12-hour pain-relieving strength of Aleve plus a sleep aid. Each caplet combines the sleep aid diphenhydramine HCl (25 mg) with the pain reliever naproxen sodium (220 mg), a nonsteroidal anti-inflammatory drug, to provide relief from occasional sleeplessness associated with minor aches and pains. It can help you fall asleep and stay asleep.
The number of U.S. measles cases confirmed this year as of April 4 reached 465, the second-highest level for any year since the nation declared the disease eliminated in 2000, according to the Centers for Disease Control and Prevention.
Class 2 Device Recall Biomet RingLoc Hip System SelfTapping Bone Screw
Class 1 Device Recall o_two e700 Automatic Transport Ventilator
Class 3 Device Recall Micro Knife 5.0mm 30
Statement from Jeff Shuren, M.D., director of the Center for Devices and Radiological Health, on agency efforts to mitigate temporary shortage of pediatric breathing tubes due to recent closure of Illinois sterilization facility
Class 2 Device Recall Stockert/Sorin HeaterCooler System 3T
The U.S. Food and Drug Administration ordered the manufacturers of all remaining surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse (POP) to stop selling and distributing their products in the U.S. immediately.
Taking a dietary supplement – like vitamins, minerals, or herbs – has become a daily routine for many Americans.
A labeling change order was issued to Sprout Pharmaceuticals last week by the Food and Drug Administration concerning its drug Addyi (flibanserin).
Encourages Florida Policymakers to Consider Alternatives to Rising Out-of-Pocket Costs
Fee rates and payment instructions for companies submitting new medical device applications to the federal Food and Drug Administration have been released for fiscal year 2019, which began on Oct. 1, 2018.
Health research group Public Citizen's founder, Sidney Wolfe, believes a moratorium on opioid production is necessary because new opioids and reformulations of opioids have more known risks than benefits.
.jpg)
The Food and Drug Administration oversees manufacturers’ postmark surveillance studies on new and significant health concerns in order to understand a device’s risks and to update policies on such risks.
Agency is also taking new steps to support development of over-the-counter and additional generics of naloxone to help reduce opioid overdose deaths, increase access to emergency treatment
The world of pharmaceuticals and biotechnology is ever-growing and changing, but seemingly only behind closed doors.
Circassia Pharmaceuticals Inc. (“Circassia” or “the Company”), today announced that the US Food and Drug Administration has approved DUAKLIR® PRESSAIR® (aclidinium bromide and formoterol fumarate) for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
.jpg){kind=tracking}
The FDA is a public health agency that always strives to use the best available scientific evidence to promote and protect the well being of individuals. I
Corey Polen was a healthy 40-year-old man enjoying his life with his wife and three children. In October of 2015 that all changed when he started feeling spurts of weakness, not thinking too much about it until it began to progress rapidly with no answers.
Voluntary recalls are one of the most important safety tools overseen by the U.S. Food and Drug Administration.